ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

NIH

  • Home
  • NIH
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • AACR
  • Acute lymphoblastic leukemia (ALL)
  • Acute myeloid leukemia
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia
  • Adolescents and young adults
  • Advanced melanoma
  • Advanced practice providers
  • Advocacy
  • Anal cancer
  • ARPA-H
  • Artificial intelligence (AI)
  • ASCO
  • ASTRO
  • Awards
  • AYA cancer
  • B-cell lymphoma
  • Big data
  • Biostatistics
  • Bladder cancer
  • Blood cancer
  • Blood cancers
  • Brain cancer
  • Breast cancer
  • Cancer
  • Cancer care delivery research
  • Cancer control
  • Cancer research
  • Cancer research policy
  • Cancer screening
  • Cancer surveillance
  • Cardiotoxicity
  • CBPF
  • Chemoimmunotherapy
  • Chemotherapy
  • Chronic lymphocytic leukemia
  • Chronic myelogenous leukemia
  • Chronic myeloid leukemia
  • Clinical trial
  • Clinical trials
  • Colorectal cancer
  • Colorectal liver metastases
  • ComboMATCH
  • Comis Symposium
  • Communication
  • Community oncology
  • Cooperative Group cancer research
  • Correlative science
  • COVID-19
  • CT scans
  • Data science
  • DCIS
  • De-escalation
  • Deep learning
  • DEI
  • Developmental therapeutics
  • Diversity
  • EGFR
  • Engineering
  • ESMO
  • Esophagus cancer
  • Ethics
  • Federally-funded cancer research
  • Financial hardship
  • Gallbladder cancer
  • Gastric cancer
  • Gastroesophageal junction cancer
  • GBM
  • Gender equity
  • Genetic testing
  • Genomics
  • Geriatric oncology
  • GI cancer
  • Glioblastoma
  • Glioma
  • GM-CSF
  • Green tea catechins
  • Group Meeting
  • GU cancer
  • Head and neck cancer
  • Head and neck squamous cell carcinoma
  • health care
  • Health care administration
  • Health equity
  • Hematologic malignancies
  • Hematology
  • Hepatic arterial infusion
  • HER2-positive breast cancer
  • Hormone therapy
  • Imaging
  • Immune checkpoint inhibitors
  • Immunotherapy
  • In memory
  • Institution Evaluation
  • Just-in-time clinical trials
  • Kidney cancer
  • Language
  • Leadership
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lung inflammation
  • Lymphoblastic lymphoma
  • Lymphoma
  • Mammography
  • Mantle cell lymphoma
  • Meetings
  • Melanoma
  • Membership
  • Mentorship
  • Merkel cell carcinoma
  • Mesothelioma
  • Misinformation
  • Multiple myeloma
  • Myelodysplastic neoplasms
  • Myelodysplastic syndromes
  • Myeloid malignancies
  • Myeloma
  • myeloMATCH
  • National Cancer Act
  • Natural language processing
  • NCI
  • NCI-Designated Comprehensive Cancer Centers
  • NCI-MATCH
  • NCORP
  • NCTN Grant
  • Neuroendocrine tumors
  • NIH
  • NIPEC
  • Non-Hodgkin lymphoma
  • Non-small cell lung cancer
  • NSCLC
  • Older adults
  • Ovarian cancer
  • Pancreatic cancer
  • Pancreatic cyst
  • Pancreatic cysts
  • Pancreatic NETs
  • Pathology
  • Patient care
  • Patient registry
  • Patient reported outcomes (PROs)
  • Patient-reported outcomes
  • Penile cancer
  • Peripheral neuropathy
  • Personalized medicine
  • Personalized screening
  • Pneumonitis
  • Policy
  • Pragmatic clinical trials
  • Precision medicine
  • Precision oncology
  • PrECOG
  • Prevention
  • Prostate cancer
  • Proteasome inhibitors
  • Public-private partnerships
  • Publications
  • Quality of life
  • Racism
  • Radiation
  • Radiology
  • Rare disease
  • Real-world data
  • Recurrence
  • Renal cell
  • Renal cell carcinoma
  • Reproductive health
  • Research results
  • Retroperitoneal sarcoma
  • Sarcoma
  • Scholarship
  • Sexuality
  • Side effects
  • Smoking cessation
  • Smoldering multiple myeloma
  • Social determinants of health
  • Social genomics
  • Stomach cancer
  • Survivorship
  • Symptom control
  • Symptom management
  • Symptom science
  • Targeted therapy
  • Throat cancer
  • Thyroid cancer
  • TMIST
  • Tobacco cessation
  • Translational research
  • Urinary tract cancer
  • Vaccination
  • Women in oncology
  • Young investigators
November 21, 2025
November 21, 2025
Categories
  • Special Topics

NIH Implements “Zero-Embargo” Revisions to its Public Access Policy for Published Scientific Research

Compliance guidance for an updated policy that aims to accelerate free public access to research funded by the National Institutes of Health
Do you like it?
0 Read more
October 17, 2025
October 17, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, October 2025

A welcome to the new National Cancer Institute director, an update on the federal budget and its implications, and a look ahead to next week's Group Meeting
Do you like it?
0 Read more
September 19, 2025
Dr. O'Dwyer and Dr. Schnall
September 19, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, September 2025

An update on the cancer research environment, a recap of the September NCAB meeting, and a preview of the fall group meeting
Do you like it?
0 Read more
August 28, 2025
Dr. O'Dwyer and Dr. Schnall
August 28, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, August 2025

An open letter from the NCTN Cooperative Group Chairs to Congress on the importance of supporting robust federal funding for cancer research
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc